Manuel Rodrigues et al.
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-39383-8
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Manuel Rodrigues et al.
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-39383-8